New eye drop put to the test in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage study is testing a new eye drop called BT01001 in 32 healthy adults to see if it is safe and how the body processes it. Participants will receive either the eye drop or a placebo (inactive drop) and be monitored for side effects. Since this is a Phase 1 trial in …
Phase: PHASE1 • Sponsor: Beyang Therapeutics Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC